Ulcerative Colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 12 Women and men with - moderate to severe ulcerative colitis (pMayo score up to 9 points) - signed consent form and - signed transfer agreement - Steroid intake with a dose below Cushing's threshold Control group: 12 people with intestinal health who undergo a screening colonoscopy and who signed of consent form for the study and who signed transfer agreement.
Exclusion criteria
Exclusion criteria: Steroid intake with a dose above Cushing's threshold pregnancy In patients with ulcerative colitis: lack of inflammation at the time of colonoscopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performance and morphology of mitochondria in the colon mucosa in ulcerative colitis compared to gut-healthy controls. Multiple biopsies of the mucosa will be taken. The capacity of the respiratory chain of the mitochondria in the colon mucosa will be examined using respirometry in the Oroboros O2K device. The morphology of the mitochondria will be examined using electron microscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| Performance and morphology of the mitochondria in the colon mucosa depending on local inflammation. For this, 8 biopsies will be taken in inflamed area of ??the colon and 8 biopsies in the non-inflamed area of ??the colon. The capacity of the respiratory chain of the mitochondria in the colon mucosa will be examined using respirometry in the Oroboros O2K device. The morphology of the mitochondria will be examined using electron microscopy | — |
Countries
Germany
Contacts
Universitätsklinik Ulm, Innere Medizin I